Panel Ecosystem Innovation track
The State of Biopharma Deal-Making in 2026: Global Trends & Strategic Shifts
Wed, Nov 11, 2026 · 9:30–9:55 AM CET Ecosystem Innovation Stage, Koelnmesse
About this session
This session offers a concise data-driven analysis of biopharma deal trends, summarizing major licensing and M&A trends across the industry during 2026. Gain insights into the growing prominence of cross-border collaborations along with the strategic drivers behind these alliances. Additionally, the session will delve into the key disease areas being prioritized for acquisition and licensing, shedding light on therapeutic focus areas, and emerging opportunities.
Speaker
-
Senior Director, Emerging Companies Special Initiatives · Biotechnology Innovation Organization (BIO)
Panelist